Lv68
1610 积分 2024-03-08 加入
Progress in the Research and Development of Biphenyl Small Molecules Targeting PD‐1/PD‐L1 as Potential Anti‐Tumor Drug Candidates
3天前
已完结
Small molecules targeting immune checkpoint proteins for cancer immunotherapy: a patent and literature review (2020-2024)
4天前
已完结
Nectin-4-directed antibody-drug conjugates (ADCs): Spotlight on preclinical and clinical evidence
7天前
已完结
DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications
8天前
已完结
Progress of ATM inhibitors: opportunities and challenges
13天前
已完结
Enhancing the bystander effect of antibody-drug conjugate by using a novel caspase-3 cleavable peptide linker to overcome tumor heterogeneity
16天前
已完结
Design, Synthesis, Evaluation, and SAR of 5-Phenylisoindoline Derivatives, a Potent Class of Small-Molecule Inhibitors Targeting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 (PD-1/PD-L1) Interaction
23天前
已完结
Discovery of Potent Isoindolinone Inhibitors that Target an Active Conformation of PARP1 Using DNA‐Encoded Libraries
24天前
已完结
Site-specific construction of triptolide-based antibody-drug conjugates
1个月前
已完结
166 (PB154): A novel HER2 targeted dual-payload ADC, HMBD-802, overcomes resistance to topoisomerase 1 inhibitor ADCs
1个月前
已完结
皖公网安备34019202002308
